CUBI vs SLDE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CUBI presents a stark contradiction between explosive growth and deteriorating fundamental health. While the Piotroski F-Score of 2/9 indicates significant weakness in financial health, the stock is fundamentally undervalued, trading well below its Graham Number ($105.14) and Intrinsic Value ($234.23). Massive YoY earnings growth (579.30%) and a low P/E of 9.37 provide a strong value proposition, but the bearish technical trend (10/100) and poor health score suggest high risk. The overall outlook is neutral until the underlying health metrics stabilize.
SLDE presents a compelling value proposition with a Piotroski F-Score of 4/9 (Stable) and a current price ($19.63) trading significantly below both its Graham Number ($26.06) and growth-based Intrinsic Value ($99.12). The company exhibits explosive earnings growth (103.9% YoY) and exceptional profitability metrics, including an ROE of 57.42%. However, this fundamental strength is sharply contrasted by aggressive insider selling and a bearish technical trend. The valuation gap is too wide to ignore, but the insider activity suggests a potential disconnect between public data and internal sentiment.
Compare Another Pair
Related Comparisons
CUBI vs SLDE: Head-to-Head Comparison
This page compares Customers Bancorp, Inc. (CUBI) and Slide Insurance Holdings, Inc. (SLDE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.